Diagnosis and Treatment of HCC Varies by Race
Blacks and Hispanics less likely to get surveillance, early diagnosis, and curative treatment by Diana Swift, Contributing Writer June 14, 2018
A large retrospective study of hepatocellular (HCC) patients in Texas found racial and ethnic differences in outcomes, with blacks and Hispanics less likely than whites to get early diagnosis and curative treatment, and blacks less likely to survive.
"Our findings have important implications for health policy and highlight the need for further study on racial-ethnic disparities in HCC, including identification of additional actionable intervention," wrote Amit Singal, MD, MS, of the University of Texas (UT) Southwestern Medical Center's Simmons Cancer in Dallas, and colleagues in Clinical Gastroenterology and Hepatology
Continue reading:
Continue reading:
Free registration may be required
No comments:
Post a Comment